Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The use of neoadjuvant immuno-chemotherapy could improve survival outcomes of patients eligible for sequential radio-chemotherapy comparing to the benefit already obtained with maintenance immunotherapy.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Zaawansowany rak płuca stadium IIIA, IIIB lub IIIC, który nie może być operacyjnie usunięty
- •Wiek powyżej 70 lat lub poniżej 70 lat z innymi schorzeniami wpływającymi na ogólny stan zdrowia
- •Dobra funkcja płuc (co najmniej 40% normy) i oddychanie
- •Wystarczająca funkcja nerek i wątroby
- •Wystarczająca liczba komórek krwi (białe krwinki, płytki, czerwone krwinki)
- •Ubezpieczenie zdrowotne
- •Obecność markera PD-L1 w guzie
✗ Disqualifies
- •Przeciwwskazania do chemioterapii lub immunoterapii
- •Kwalifikowalność do jednoczesnej radioterapii i chemioterapii
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 11, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (25)
Angers - Centre Paul Papin
Angers, France
Angers - CHU
Angers, France
Avignon - CH
Avignon, France
Boulogne - Ambroise Paré
Boulogne, France
Brest - CHU
Brest, France
Caen - CHU
Caen, France
Caen - CRLCC
Caen, France
Créteil - CHI
Créteil, France
Dijon - CRLCC
Dijon, France
Le Mans - CHG
Le Mans, France
Lille - CRLCC
Lille, France
Marseille - APHM
Marseille, France
Mulhouse - GHRMSA
Mulhouse, France
Paris - Bichat
Paris, France
Paris - Hôpital Cochin
Paris, France
Paris - Tenon
Paris, France
Bordeaux - CHU
Pessac, France
Lyon - HCL
Pierre-Bénite, France
Rennes - CHU
Rennes, France
Rouen - Centre Henri Becquerel
Rouen, France
Nantes - CRLCC
Saint-Herblain, France
Strasbourg - CRLCC
Strasbourg, France
Toulouse - CHU
Toulouse, France
Tours - CHU
Tours, France
Vandoeuvre-lès-Nancy - CRLCC
Vandœuvre-lès-Nancy, France
Trial contact
Contact IFCT
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/12/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.